{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-038742","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.488106+00:00","generated_at":"2026-06-04T07:36:30.433396+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bio-Path raises ~$299k in registered direct offering; issues warrants","bullets":["Gross proceeds of $299,250 from 75,000 shares at $3.99/share; net ~$0.2M after fees.","Common warrants to purchase up to 75,000 shares at $3.865, 5-year term, immediate exercise.","Placement agent H.C. Wainwright gets 7.5% fee plus warrants for 5,625 shares at $4.9875.","Proceeds for working capital; closing expected March 27, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-038742","json":"https://secwatch.observer/filing/0001104659-24-038742.json","markdown":"https://secwatch.observer/filing/0001104659-24-038742.md","text":"https://secwatch.observer/filing/0001104659-24-038742.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000110465924038742/0001104659-24-038742-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000110465924038742/tm249787d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:36:30.433396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e5b872a0b869aa325ebe2e5a46c8c84e5537985","claim":"BIO-PATH HOLDINGS, INC. entered into Purchase Agreement with an institutional investor valued at gross proceeds of $299,250 (effective 2024-03-25).","evidence_excerpt":"On March 25, 2024, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor, pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 75,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $3.99 and gross proceeds of $299,250.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133818/000110465924038742/0001104659-24-038742-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Value","value":"gross proceeds of $299,250"},{"label":"Effective","value":"2024-03-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}